Research Report: WST

Analysis Date: 2025-12-29T01:08:27.196182 Trading Period: 2025-12-25 to 2026-01-08

Company Overview

Company: West Pharmaceutical Services, Inc. Sector: Healthcare | Industry: Medical Instruments & Supplies Current Price: $274.30 Market Cap: $19,734,075,392 Beta: 1.17 Avg Volume: 703,042 P/E Ratio: 40.64 Website: https://www.westpharma.com

Description: West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applicati...

Trading Recommendation

Action: STRONG AVOID Confidence: 20.0/100 Position Size: 0.0% of portfolio

Rationale: Unfavorable conditions (composite: 7.4/100, risk: EXTREME, red flags: 1).

Key Risks:

Screening Status

Passed Filters: ✗ No Notes: Failed one or more screening filters (volume, price, market cap, etc.)

Quantitative Analysis

Composite Score: 0.00/5.0 Percentile Rank: 0%

Factor Scores:

Technical Analysis

Setup Score: 1/8 Setup Notes: In uptrend

Price Levels:

Momentum & Volume:

Risk Assessment

Risk Level: EXTREME Confidence: 10.0/100 Total Red Flags: 1 Earnings Risk: No

Stock-Specific Red Flags:


This report is generated by PM automated research system. Always perform your own due diligence before trading.